Cargando…
Carbamylated erythropoietin regulates immune responses and promotes long-term kidney allograft survival through activation of PI3K/AKT signaling
Modulation of alloimmune responses is critical to improving transplant outcome and promoting long-term graft survival. To determine mechanisms by which a nonhematopoietic erythropoietin (EPO) derivative, carbamylated EPO (CEPO), regulates innate and adaptive immune cells and affects renal allograft...
Autores principales: | Na, Ning, Zhao, Daqiang, Zhang, Jinhua, Wu, Jiaqing, Miao, Bin, Li, Heng, Luo, Yingxun, Tang, Zuofu, Zhang, Wensheng, Bellanti, Joseph A., Zheng, Song Guo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7493938/ https://www.ncbi.nlm.nih.gov/pubmed/32934199 http://dx.doi.org/10.1038/s41392-020-00232-5 |
Ejemplares similares
-
Carbamylated erythropoietin attenuates cardiomyopathy via PI3K/Akt activation in rats with diabetic cardiomyopathy
por: HE, HONGYING, et al.
Publicado: (2013) -
Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection
por: Chen, Jianmin, et al.
Publicado: (2016) -
Correction to: “Carbamylated Erythropoietin: A Prospective Drug Candidate for Neuroprotection”
por: Chen, Jianmin, et al.
Publicado: (2016) -
Renoprotective effect of erythropoietin via modulation of the STAT6/MAPK/NF-κB pathway in ischemia/reperfusion injury after renal transplantation
por: Zhang, Jinhua, et al.
Publicado: (2018) -
Molecular mechanism of the role of carbamyl erythropoietin in treating diabetic retinopathy rats
por: Xu, Xuegu, et al.
Publicado: (2018)